'Snowzilla' Delays Drug Price Hearing; Shkreli Travel OK'd
This article was originally published in Scrip
Executive Summary
A federal judge has given his OK for Martin Shkreli – the former Turing Pharmaceuticals Inc. CEO Americans love to hate and who has become despised among the big players in the biopharmaceutical industry – to travel to Washington to comply with a subpoena issued by lawmakers summoning him to a hearing on drug prices.